Literature DB >> 24278570

Estrogenic Activity of Persistent Organic Pollutants and Parabens Based on the Stably Transfected Human Estrogen Receptor-α Transcriptional Activation Assay (OECD TG 455).

Tae Sung Kim1, Chang Yeong Kim, Hae Kyung Lee, Il Hyun Kang, Mi Gyeong Kim, Ki Kyung Jung, Yong Kwan Kwon, Hye-Seon Nam, Soon Keun Hong, Hyung Sik Kim, Hae Jung Yoon, Gyu Seek Rhee.   

Abstract

Screening of estrogenic activity on dichloro diphenyl trichloroethane (DDT), dichloro diphenyl dichloro ethylene (DDE), dieldrin, heptachlor, aldrin, chlordane, lindane, polybrominated diphenyl ethers (PBDE) and parabens was compared using Organization for Economic Cooperation and Development (OECD) test guideline 455 (TG455). The estrogenic activity of DDT was 58,000-fold (PC50, 1.67 × 10(-6) M) less than 17β-estradiol(E2) (PC50, 2.88 × 10(-11) M) but DDE, dieldrin, heptachlor, aldrin, chlordane, lindane and PBDE did not show any estrogenic activity in this assay system. In the case of paraben compounds, the rank of relative transcriptional activation (logRTA) was butyl paraben -1.63752 (PC50, 1.25 × 10(-7)M) > isobutyl paraben -2.34008 (PC50, 6.3 × 10(-7)M) > ethyl paraben -2.64016 (PC50, 1.26 × 10(-6) M) > isopropyl paraben -2.73993 (PC50, 1.58 × 10(-6)M) > propyl paraben -2.84164 (PC50, 2.0 × 10(-6) M). Our data suggest that OECD test guideline TG455 may be useful as a screening tool for potential endocrine disruptors.

Entities:  

Keywords:  DDT; Endocrine disruptors; Estrogenic activity; OECD test guideline 455; Parabens

Year:  2011        PMID: 24278570      PMCID: PMC3834384          DOI: 10.5487/TR.2011.27.3.181

Source DB:  PubMed          Journal:  Toxicol Res        ISSN: 1976-8257


INTRODUCTION

Endocrine disruptors (EDCs) may be interfered the endocrine system in wildlife and humans reproduction (Colborn ; Vos ; Bonefeld-Jorgensen . They mimic, compete, block or alter the activities of endogenous hormones. Previous studies have been reported that endocrine disruptors interrupt interactions of ligandreceptor binding that act as receptor agonist or antagonist (Hunter ; Damdimopoulos . For rapid alarming health and environmental consequences involved fast and reliable approaches are needed. Based on these situation, the Organization for Economic Cooperation and Development (OECD) conceptual framework for testing and assessment of man-made compounds comprised five levels and in vitro screening methods for alternative animal study ranked as level 2 (OECD, 2003). Recently, the stably transfected transcriptional activation assay (STTA) developed by Chemicals Evaluation and Research Institute (CERI) have been accepted as the OECD test guideline 455 (TG455) in 2009 (OECD, 2009). The STTA assay is to evaluate the ability of chemicals to function as an estrogen receptor alpha (ERα) ligand and activate an ERα agonistic responses. Here, we validated the estrogenic activity of persistent organic pollutants DDT, DDE, dieldrin, heptachlor, aldrin, chlordane, lindane, PBDE) and parabens using STTA assay. Previous studies have been indicated that these compounds showed weak or potent estrogenic activity using in vitro and in vivo screening assay systems (Okubo ; Vo and Jeung .

MATERIALS AND METHODS

The hERα-HeLa- 9903 cell line (HeLa9903) which is stably transfected a human ERα gene containing a firefly luciferase gene as a reporter gene was provided from the CERI. The experiments were performed with 5~28 passages of the cells, which were seeded at 1 × 104 cells per well on 96 well plates and incubated cells for 3 hr at 37℃ with 5% CO2. The reagents of cell culture used commercial products except Dextran-coated charcoal treated fetal bovine serum (DCCFBS, provided from CERI). The cells were maintained and tested in 10% DCC-FBS-EMEM including 7.5% NaHCO3, 4 mM L-glutamine and 10% DCC-FBS. Reference chemicals: 10 mM 17α-estradiol (Sigma, St. Louis, MO, USA), 10 mM 17β-estradiol (E2, Sigma, St. Louis, USA), and 100 mM corticosterone (Wako, Japan) were prepared in dimethyl sulfoxide (DMSO, Sigma) as the stock solution. Test chemicals: dichloro diphenyl trichloroethane (DDT, Supelco, St. Louis), dichloro diphenyl dichloro ethylene (DDE, Sigma, St. Louis, USA), dieldrin (Chem Service, USA), heptachlor (Supelco, St. Louis, USA), aldrin (Chem Service, USA), chlordane (Chem Service, USA), lindane (Supelco, St. Louis, USA), polybrominated diphenyl ethers (PBDE, Chem Service, USA), butyl paraben (Sigma, St. Louis, USA), ethyl paraben (Aldrich, St. Louis, USA), propyl paraben (Aldrich, St. Louis, USA), isobutyl paraben (Wako, Japan), isopropyl paraben (Wako, Japan) were obtained in commercially available. All test chemicals were prepared at log-serial dilutions (10−5~10−10 M) with DMSO. The luciferase activities were determined in accordance with OECD TG 455. Cells were exposed with reference chemicals and serially diluted test chemicals, and then were incubated for 20~24 hrs (at 37℃ 5% CO2). The media on the cell plates were removed then added 50l of luciferase solution (Steady-Glo Luciferase Assay kit, Promega) and the activities were measured by a Luminometer (US Microplate Scintillation and Luminescence Counter, Packard). The fold induction of E2 (1 nM), at least 4-fold grater than the mean vehicle control (VC), and the values of the PC50 (17α-estradiol, corticosterone and test compounds) were obtained from provided spreadsheet using GraphPad Prism software (GraphPad Software Inc., San Diego, CA). The RTA value of the estrogen activities were obtained from ratios of PC50 of test chemicals with PC50 of E2.

RESULTS AND DISCUSSION

The estrogenic activities of persistent organic pollutants (DDT, DDE, dieldrin, heptachlor, aldrin, chlordane, lindane, PBDE) were determined by STTA assay. In the validation study for this assay system, the quality control and standard curve were coincident with criteria TG455 (Table 1 and Fig. 1). In this study, DDT showed a weak estrogenic activity which was 58,000-fold lower than that of E2. However, DDE, dieldrin, heptachlor, aldrin, chlordane, lindane and PBDE did not show any estrogenic activity (Table 2 and Fig. 2). As showed in Table 4, previous studies indicated that the relative estrogenic activity of DDT against E2 detected by 3 different assay systems (Coldham ; Soto . DDT showed higher relative estrogenic activity in STTA assay as compare with that of Yeast and E-screen assays.
Table 1.

Performance and quality control criteria for the STTA assay

Reference chemicalsAcceptable criteria Log[PC50M]Result

17β-estradiol (E2)−11.4~−10.1−10.54~
17α-estradiol (α E2)−9.6~−8.1  −8.64~
Corticosterone*--

*Corticosterone is used for negative control.

Fig. 1.

The final concentration of each well for reference chemicals. E2 and α E2, positive control; cor, negative control.

Table 2.

PC50 and logRTA values for STTA assay (persistent organic pollutants)

Test chemicalsSTTA assay

PC50(M)logRTA*

17β-estradiol2.88 × 10−112
17α-estradiol3.0 × 10−9−0.01773
Dichloro diphenyl trichloroethane (DDT)1.67 × 10−6−2.76447
Dichloro diphenyl dichloro ethylene (DDE)NegativeNegative
DieldrinNegativeNegative
HeptachlorNegativeNegative
AldrinNegativeNegative
ChlordaneNegativeNegative
LindaneNegativeNegative
Polybrominated diphenyl ethers (PBDE)NegativeNegative

*Relative transcriptional activation is calculated as 100 × (PC50) of E2/(PC50) of test compound; a value of 100 indicates that the compound tested is a full agonist.

Abbreviations: RTA, Relative transcriptional activation; PC50, the concentration of chemical estimated to cause 50% of activity of the positive control response on a plate by plate basis.

Fig. 2.

The final concentration of each well for persistent organic pollutants and reference chemicals.

Table 4.

Comparison of in vitro assay for dichloro diphenyl trichloroethane (DDT)

Test chemicalsYeast assayE-screen assaySTTA assay

Coldhama logRPSotob logRPPThis study logRTA

17β- estradiol2  22
Dichloro diphenyl trichloroethane (DDT)−4.52−4−2.76

a: data from Coldham , b: data from Soto .

Abbreviations: E2, 17β-estradiol; RP, relative potency compared to E2 (100) by molar mass determined with the recombinant yeast bioassay; RPP, relative proliferative potency is the ratio between 17β-estradiol and xenoestrogen doses needed to produce maximal cell yields ×100; RTA, Relative transcriptional activation.

Performance and quality control criteria for the STTA assay *Corticosterone is used for negative control. PC50 and logRTA values for STTA assay (persistent organic pollutants) *Relative transcriptional activation is calculated as 100 × (PC50) of E2/(PC50) of test compound; a value of 100 indicates that the compound tested is a full agonist. Abbreviations: RTA, Relative transcriptional activation; PC50, the concentration of chemical estimated to cause 50% of activity of the positive control response on a plate by plate basis. PC50 and logRTA values for STTA assay (parabens) *Relative transcriptional activation is calculated as 100 × (PC50) of E2/(PC50) of test compound, a value of 100 indicates that the compound tested is a full agonist. Abbreviations: RTA, Relative transcriptional activation; PC50, the concentration of chemical estimated to cause 50% of activity of the positive control response on a plate by plate basis. The estrogenic activities of parabens (butyl-, ethyl-, propyl-, isobutyl-, and isopropyl- paraben) were determined by STTA assay. Butyl-, ethyl-, propyl-, isobutyl- and isopropyl paraben showed lower estrogenic activity than E2 (Table 3 and Fig. 3). The rank of logRTA on the parabens was butyl paraben −1.63752 (PC50, 1.25 × 10−7 M) > isobutyl paraben −2.34008 (PC50, 6.3 × 10−7 M) > ethyl paraben −2.64016 (PC50, 1.26 × 10−6 M) > isopropyl paraben −2.73993 (PC50, 1.58 × 10−6 M) > propyl paraben −2.84164 (PC50, 2.0 × 10−6 M). Butyl-, isobutyl- ethyl-, isopropyl-, and propyl paraben were shown weak estrogenic activities which were approximately 4,300-fold, 22,000-fold, 44,000-fold, 55,000-fold, 69,000-fold lower than E2. Butyl-, ethyl- and propyl paraben were all estrogenic in a yeast-based estrogen assay, with the most potent butyl paraben being 10,000 times less potent than E2 (Routledge ; Terasaki et al., 2009). The relative estrogenic activity of parabens against E2 using 2 different assays were indicated in Table 5. Okubo had shown that the relative estrogenic activity of parabens using MCF-7 cell proliferation assays. Butyl paraben, ethyl paraben and propyl paraben showed higher relative estrogenic activity in STTA assay as compare with that of MCF-7 cell proliferation assay.
Table 3.

PC50 and logRTA values for STTA assay (parabens)

Test chemicalsSTTA assay

PC50 (M)logRTA*

17β-estradiol  2.88 × 10−112
17α-estradiol  3.0 × 10−9−0.01773
Butyl paraben1.25 × 10−7−1.63752
Ethyl paraben1.26 × 10−6−2.64016
Propyl paraben  2.0 × 10−6−2.84164
Isobutyl paraben  6.3 × 10−7−2.34008
Isopropyl paraben1.58 × 10−6−2.73993

*Relative transcriptional activation is calculated as 100 × (PC50) of E2/(PC50) of test compound, a value of 100 indicates that the compound tested is a full agonist.

Abbreviations: RTA, Relative transcriptional activation; PC50, the concentration of chemical estimated to cause 50% of activity of the positive control response on a plate by plate basis.

Fig. 3.

The final concentration of each well for parabens and reference chemicals.

Table 5.

Comparison of in vitro assay for parabens

Test chemicalsMCF-7 cell proliferation assaySTTA assay

Okuboa logRPPThis study logRTA

17β-estradiol22
Butyl paraben−3.82−1.64
Ethyl paraben−3.82−2.64
Propyl paraben−3.82−2.84
Isobutyl paraben−2.22−2.34
Isopropyl paraben−2.22−2.74

a: data from Okubo et al. (2001).

Abbreviations: E2, 17β-estradiol; RPP, relative proliferative potency is the ratio between 17β-estradiol and xenoestrogen doses needed to produce maximal cell yields ×100; RTA, Relative transcriptional activation.

Comparison of in vitro assay for dichloro diphenyl trichloroethane (DDT) a: data from Coldham , b: data from Soto . Abbreviations: E2, 17β-estradiol; RP, relative potency compared to E2 (100) by molar mass determined with the recombinant yeast bioassay; RPP, relative proliferative potency is the ratio between 17β-estradiol and xenoestrogen doses needed to produce maximal cell yields ×100; RTA, Relative transcriptional activation. Comparison of in vitro assay for parabens a: data from Okubo et al. (2001). Abbreviations: E2, 17β-estradiol; RPP, relative proliferative potency is the ratio between 17β-estradiol and xenoestrogen doses needed to produce maximal cell yields ×100; RTA, Relative transcriptional activation. In conclusion, STTA assay is useful and corresponds with other in vitro studies based on relative estrogenic activity. Our present results indicate that DDT and parabens (butyl-, ethyl-, propyl-, isobutyl- and isopropyl- paraben) act as weak estrogen agonist by human ERα mediated transcriptional activation.
  11 in total

Review 1.  Health effects of endocrine-disrupting chemicals on wildlife, with special reference to the European situation.

Authors:  J G Vos; E Dybing; H A Greim; O Ladefoged; C Lambré; J V Tarazona; I Brandt; A D Vethaak
Journal:  Crit Rev Toxicol       Date:  2000-01       Impact factor: 5.635

2.  Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium.

Authors:  D S Hunter; L C Hodges; P M Vonier; R Fuchs-Young; M M Gottardis; C L Walker
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

Review 3.  Safety assessment of esters of p-hydroxybenzoic acid (parabens).

Authors:  M G Soni; I G Carabin; G A Burdock
Journal:  Food Chem Toxicol       Date:  2005-07       Impact factor: 6.023

4.  ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR.

Authors:  T Okubo; Y Yokoyama; K Kano; I Kano
Journal:  Food Chem Toxicol       Date:  2001-12       Impact factor: 6.023

Review 5.  The Human Health Effect Programme in Greenland, a review.

Authors:  Eva Cecilie Bonefeld-Jørgensen
Journal:  Sci Total Environ       Date:  2004-09-20       Impact factor: 7.963

6.  Ligands differentially modify the nuclear mobility of estrogen receptors alpha and beta.

Authors:  Anastasios E Damdimopoulos; Giannis Spyrou; Jan-Ake Gustafsson
Journal:  Endocrinology       Date:  2007-09-20       Impact factor: 4.736

7.  An evaluation of estrogenic activity of parabens using uterine calbindin-d9k gene in an immature rat model.

Authors:  Thuy T B Vo; Eui-Bae Jeung
Journal:  Toxicol Sci       Date:  2009-08-04       Impact factor: 4.849

8.  Evaluation of a recombinant yeast cell estrogen screening assay.

Authors:  N G Coldham; M Dave; S Sivapathasundaram; D P McDonnell; C Connor; M J Sauer
Journal:  Environ Health Perspect       Date:  1997-07       Impact factor: 9.031

Review 9.  Developmental effects of endocrine-disrupting chemicals in wildlife and humans.

Authors:  T Colborn; F S vom Saal; A M Soto
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

10.  The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants.

Authors:  A M Soto; C Sonnenschein; K L Chung; M F Fernandez; N Olea; F O Serrano
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

View more
  3 in total

1.  Organochlorine insecticides DDT and chlordane in relation to survival following breast cancer.

Authors:  Humberto Parada; Mary S Wolff; Lawrence S Engel; Alexandra J White; Sybil M Eng; Rebecca J Cleveland; Nikhil K Khankari; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon
Journal:  Int J Cancer       Date:  2015-08-27       Impact factor: 7.396

2.  Endocrine disrupting potency of organic pollutant mixtures isolated from commercial fish oil evaluated in yeast-based bioassays.

Authors:  Marek Łukasz Roszko; Marta Kamińska; Krystyna Szymczyk; Katarzyna Piasecka-Jóźwiak; Beata Chabłowska
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

3.  Environmental Phenol and Paraben Exposure Risks and Their Potential Influence on the Gene Expression Involved in the Prognosis of Prostate Cancer.

Authors:  Diaaidden Alwadi; Quentin Felty; Deodutta Roy; Changwon Yoo; Alok Deoraj
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.